Furthermore, several studies have reported that the gluconeogenic enzyme PCK1 is suppressed in cancer tissues and functions as a tumor suppressor in gluconeogenic organs such as the liver and kidney (Ma et al., 2013; Liu et al., 2018b; Tang et al., 2018). The gene discussed is PCK1; the disease is cancer.